This article uses bare URLs, which may be threatened by link rot. (May 2021) (Learn how and when to remove this template message)
|Born||14 February 1956|
|Institutions||University of Pennsylvania School of Medicine|
|Thesis||Studies on the FBJ murine osteogeneic sarcoma virus complex (1982)|
Thomas Curran FRS is a Scottish medical researcher. He is the Executive Director and Chief Scientific Officer of the Children’s Mercy Research Institute at Children’s Mercy Hospital in Kansas City, Missouri, where he is also the Donald J. Hall Eminent Scholar in Pediatric Research. He is also a Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and a Professor of Cancer Biology at the University of Kansas School of Medicine.Before taking his current positions in 2016, he was a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine, where he also served as Associate Director of Translational Genomics at the Penn Genome Frontiers Institute.
Curran was educated at the University of Edinburgh where he was awarded a Bachelor of Science degree in 1978.He was awarded a PhD from University College London in 1982 for studies on the murine osteogeneic sarcoma virus complex
He was chairman of the department of developmental neurobiology at St. Jude Children's Research Hospital.
He was president of the American Association for Cancer Research in 2000.He is a member of the Institute of Medicine.
Curran was elected a Fellow of the Royal Society in 2005.
Harold Eliot Varmus is an American Nobel Prize-winning scientist who was director of the National Institutes of Health from 1993 to 1999 and the 14th Director of the National Cancer Institute from 2010 to 2015, a post to which he was appointed by President Barack Obama. He was a co-recipient of the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviral oncogenes. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
Howard Martin Temin was a US geneticist and virologist. He discovered reverse transcriptase in the 1970s at the University of Wisconsin–Madison, for which he shared the 1975 Nobel Prize in Physiology or Medicine with Renato Dulbecco and David Baltimore.
Peter Charles Doherty is an Australian veterinary surgeon and Nobel laureate. He received the Albert Lasker Award for Basic Medical Research in 1995, the Nobel Prize in Physiology or Medicine jointly with Rolf M. Zinkernagel in 1996 and was named Australian of the Year in 1997. In the Australia Day Honours of 1997, he was named a Companion of the Order of Australia for his work with Zinkernagel. He is also a National Trust Australian Living Treasure. In 2009 as part of the Q150 celebrations, Doherty's immune system research was announced as one of the Q150 Icons of Queensland for its role as an iconic "innovation and invention".
John Michael Bishop is an American immunologist and microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine with Harold E. Varmus and was co-winner of 1984 Alfred P. Sloan Prize. He serves as an active faculty member at the University of California, San Francisco (UCSF), where he also served as chancellor from 1998 to 2009.
The Eli and Edythe L. Broad Institute of MIT and Harvard, often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.
The Heinrich Pette Institute, Leibniz Institute for Experimental Virology was founded in 1948 by Heinrich Pette, a German neurologist. It began as a research facility to create a polio vaccine. It is now a private foundation and involved with basic research in virology and the immune responses of organisms. The institute is a non-profit public beneficiary organisation and an independent member of the Leibniz Association, located in Hamburg.
Piers David Nash is an entrepreneur, cancer biology professor, data evangelist, writer and technology futurist. He is the son of academic Roger Nash.
Children's Mercy Hospital is a 367-bed comprehensive pediatric medical center in Kansas City, Missouri that integrates clinical care, research and medical education to provide care for patients ages birth to 21. The hospital's primary service area covers a 150-county area in Missouri and Kansas. Children's Mercy has received national recognition from U.S. News & World Report in ten pediatric specialties. The hospital was the first in Missouri and Kansas to receive Magnet Recognition for excellence in nursing services from the American Nurses Credentialing Center, and has been re-designated five times.
The International Cancer Genome Consortium (ICGC) is a voluntary scientific organization that provides a forum for collaboration among the world's leading cancer and genomic researchers. The ICGC was launched in 2008 to coordinate large-scale cancer genome studies in tumours from 50 cancer types and/or subtypes that are of main importance across the globe.
Tyler Jacks is a Professor of Biology at the Massachusetts Institute of Technology (MIT), an HHMI investigator, and director of the David H. Koch Institute for Integrative Cancer Research, which brings together biologists and engineers to improve detection, diagnosis, and treatment of cancer.
Anil Potti is a physician and former Duke University associate professor and cancer researcher, focusing on oncogenomics. He, along with Joseph Nevins, are at the center of a research fabrication scandal at Duke University. On 9 November 2015, the Office of Research Integrity (ORI) found that Potti had engaged in research misconduct. According to Potti's voluntary settlement agreement with ORI, Potti can continue to perform research with the requirement of supervision until year 2020, while he "neither admits nor denies ORI's findings of research misconduct." As of 2020 Potti, who is employed at the Cancer Center of North Dakota, has had 11 of his research publications retracted, one publication has received an expression of concern, and two others have been corrected.
Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.
Joan S. Brugge is the Louise Foote Pfeiffer Professor of Cell Biology and the Director of the Ludwig Center at Harvard Medical School, where she also served as the Chair of the Department of Cell Biology from 2004 to 2014. Her research focuses on cancer biology, and she has been recognized for her explorations into the Rous sarcoma virus, extracellular matrix adhesion, and epithelial tumor progression in breast cancer.
James W. Curran is professor of epidemiology and dean of the Rollins School of Public Health at Emory University. He is an adjunct Professor of Medicine and Nursing, and Co-Director and Principal Investigator of the Emory Center for AIDS Research. He is immediate past chair of the board on Population Health and Public Health Practice of the Institute of Medicine and served on the Executive Committee of the Association of Schools of Public Health. Additionally, he holds an endowed chair known as the James W. Curran Dean of Public Health. Dr. Curran is considered to be a pioneer, leader, and expert in the field of HIV/AIDS.
Sandra L. Quackenbush is an American virologist working as an Associate Professor of Retrovirology at the Colorado State University College of Veterinary Medicine and Biomedical Sciences. Quackenbush also serves as the Associate Head of Graduate Education for the Microbiology, Immunology & Pathology Department within the college. Her research interests include viral pathogenesis, with emphasis in viral-induced oncogenesis.
Walter "Wally" J. Curran, Jr. is an American radiation oncologist specializing in the treatment of malignant brain tumors and locally advanced lung cancer. He is the global chief medical officer of GenesisCare, a provider of cancer and cardiovascular care that serves communities in 440 locations across the world.
Dean Hamilton Kedes is an American scientist in the field of virology and current director of the medical scientist training program at the University of Virginia school of medicine.
(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.
Professor Carlos Caldas is a clinician scientist and Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. He is the Chair of Cancer Medicine at the University of Cambridge, an Honorary Consultant Medical Oncologist at Addenbrooke's Hospital and Director of the Cambridge Breast Cancer Research Unit. He is a fellow of Robinson College, Cambridge.
Werner H. Kirsten was a German-American cancer researcher, known as the discoverer and namesake of Kirsten Rat Sarcoma Virus, and consequently of the KRAS oncogene.